Biomarkers Market by Type (Efficacy, Pharmacodynamics, Predictive), Product & Service (Consumables, Services, Software), Disease, Application - Global Forecast 2024-2030

Biomarkers Market by Type (Efficacy, Pharmacodynamics, Predictive), Product & Service (Consumables, Services, Software), Disease, Application - Global Forecast 2024-2030


The Biomarkers Market size was estimated at USD 60.67 billion in 2023 and expected to reach USD 68.98 billion in 2024, at a CAGR 14.19% to reach USD 153.67 billion by 2030.

Global Biomarkers MarketThe usage of biomarkers is significantly growing to track the presence or progression of diseases and the effectiveness of treatments. These biomarkers are enabled to track and predict patient health conditions, including blood pressure or cholesterol levels. Moreover, cancer biomarkers can be utilized for diagnosis, prognosis and help to estimate cancer stage, subtype, and prediction for treatment response. These biomarkers are essential for the development of personalized or precision medicine. Additionally, these biomarkers are used in drug development processes for various purposes, including identifying the mechanism of action of drugs, drug target selection, enrichment, dose selection, safety assessment, efficacy assessment, and preclinical safety assessment. Furthermore, the need for biomarkers testing is increasing to enhance the monitoring treatment of chronic disease by detecting or confirming the presence of a disease. However, high production costs and difficulties in collecting and preserving samples in biomarkers procedures are hampering the market's growth. Moreover, advancements in the development of cancer prognostic and diagnostic biomarkers are catering to opportunities for market growth.Regional InsightsThe growing cases of chronic diseases across the Americas has increased the need for biomarkers that allow researchers and clinicians to define the status of a disease which further develops novel therapies. The American Cancer Society estimated approximately 1.9 million new diagnosed cancers in 2022, which further expanded the usage of biomarkers for the development of personalized medicine. Additionally, the U.S. and UK governments are heavily investing in the research and development (R&D) in various areas, including tumor profiling, to improve cancer care and develop biomarkers for more effective drugs. In addition, government funding for research and development and increasing the number of clinical trials across Asia-Pacific countries, such as China, India, Vietnam, and South Korea, are expected to create opportunities for the biomarkers market across Asia-Pacific region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomarkers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomarkers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biomarkers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alto Neuroscience,Inc., APIS Assay Technologies Limited, Augurex Life Sciences Corp, Bio-Rad Laboratories, Inc., BioAgilytix, Biocrates Life Sciences AG, Biofourmis Inc., Biognosys AG, BIOINFRA Life Science Inc., BioStarks, BioVision Inc., Charles River Laboratories, Inc., Clarigent Corporation, EKF Diagnostics Holdings PLC, Elo Health, Inc., F. Hoffmann-La Roche, Ltd., Merck KgaA, Nightingale Health Plc, Owkin Inc., Owlstone Medical Limited, PerkinElmer, Inc., Personalis, Inc., Proteomedix AG, QIAGEN GmbH, Renalytix PLC, Siemens Healthcare GmbH, Sino Biological Inc., Thermo Fisher Scientific, Inc., and VivoSense, Inc..

Market Segmentation & Coverage



This research report categorizes the Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Efficacy
Pharmacodynamics
Predictive
Prognostic
Safety
Surrogate
Validation
Product & Service
Consumables
Services
Software
Disease
Cancer
Cardiovascular Diseases
Immunological Diseases
Infectious Diseases
Neurological Diseases
Application
Diagnostic
Disease Risk Assessment
Drug Discovery & Development
Personalized Medicine
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biomarkers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomarkers Market?
3. What are the technology trends and regulatory frameworks in the Biomarkers Market?
4. What is the market share of the leading vendors in the Biomarkers Market?
5. Which modes and strategic moves are suitable for entering the Biomarkers Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biomarkers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing usage of biomarkers testing owing to monitor the treatment of chronic disease
5.1.1.2. Increasing biomarkers diagnostic application for personalized medicine
5.1.1.3. Rising research and development activities in biotechnology and pharmaceutical sector
5.1.2. Restraints
5.1.2.1. High cost associated with production and lengthy time process for biomarkers development
5.1.3. Opportunities
5.1.3.1. Recent advancements in the development of prognostic and diagnostic
biomarkers for cancer treatments
5.1.3.2. Integration of advanced technologies to develop biomarkers that provide high accuracy
5.1.4. Challenges
5.1.4.1. Issues associated with collection and storage of samples in biomarkers
procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biomarkers Market, by Type
6.1. Introduction
6.2. Efficacy
6.3. Pharmacodynamics
6.4. Predictive
6.5. Prognostic
6.6. Safety
6.7. Surrogate
6.8. Validation
7. Biomarkers Market, by Product & Service
7.1. Introduction
7.2. Consumables
7.3. Services
7.4. Software
8. Biomarkers Market, by Disease
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Immunological Diseases
8.5. Infectious Diseases
8.6. Neurological Diseases
9. Biomarkers Market, by Application
9.1. Introduction
9.2. Diagnostic
9.3. Disease Risk Assessment
9.4. Drug Discovery & Development
9.5. Personalized Medicine
10. Americas Biomarkers Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biomarkers Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Biomarkers Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Theralink Acquires Immunotherapy Biomarker Patent From Vanderbilt University
13.3.1.2. Mainz Biomed Acquires Entire Intellectual Property Portfolio For Its Colorectal Cancer Diagnostic Test Program
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. ObvioHealth Signs R&D Partnership with A*STAR to Identify and Develop Novel Digital Biomarkers
13.3.2.2. PrecisionLife Completes Agreement with King’s College London to Enable New Precision Neuroscience Treatments in MND/ALS
13.3.2.3. AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Strategic Partnership to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration
13.3.2.4. Vocal Biomarker Agreement Set To Benefit Patients With COPD in India
13.3.3. New Product Launch & Enhancement
13.3.3.1. Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
13.3.4. Investment & Funding
13.3.4.1. Genialis Raises USD 13 Million to Build Clinical Biomarkers that Predict Patient Response
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Abbott Receives FDA Clearance For First Commercially Available Lab-Based Blood Test To Help Evaluate Concussion
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Alto Neuroscience,Inc.
14.1.3. APIS Assay Technologies Limited
14.1.4. Augurex Life Sciences Corp
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. BioAgilytix
14.1.7. Biocrates Life Sciences AG
14.1.8. Biofourmis Inc.
14.1.9. Biognosys AG
14.1.10. BIOINFRA Life Science Inc.
14.1.11. BioStarks
14.1.12. BioVision Inc.
14.1.13. Charles River Laboratories, Inc.
14.1.14. Clarigent Corporation
14.1.15. EKF Diagnostics Holdings PLC
14.1.16. Elo Health, Inc.
14.1.17. F. Hoffmann-La Roche, Ltd.
14.1.18. Merck KgaA
14.1.19. Nightingale Health Plc
14.1.20. Owkin Inc.
14.1.21. Owlstone Medical Limited
14.1.22. PerkinElmer, Inc.
14.1.23. Personalis, Inc.
14.1.24. Proteomedix AG
14.1.25. QIAGEN GmbH
14.1.26. Renalytix PLC
14.1.27. Siemens Healthcare GmbH
14.1.28. Sino Biological Inc.
14.1.29. Thermo Fisher Scientific, Inc.
14.1.30. VivoSense, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. BIOMARKERS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOMARKERS MARKET DYNAMICS
FIGURE 7. BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 10. BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 12. BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings